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Over the past years, a wide number of chelators has been synthetized in order to 
complex a diversity of metal ions useful in medical imaging. DOTA (1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid), is an adequate chelator for Gd(III) and 
Ga(III) due to the high kinetic and thermodynamic stabilities of the metal complexes (for MRI 
(magnetic resonance imaging) and PET (positron emission tomography) respectively) [1]. 
In this work, the DOTA-based chelator DO3AAHA (1,4,7,10-tetraazacyclododecane-1-
(6-amino)hexanoic-4,7,10-triacetic acid – Figure 1a) was synthesized and characterized. 
DO3AAHA acts as a bifunctional chelator due to the pendant free amino group. This group 
can be easily conjugated to biomolecules such as peptides or anti-bodies [2]. The Gd(III) and 
Ga(III) complexes of these conjugates do not compromise the kinetic and thermodynamic 
stabilities in relation to those of the analogous DOTA chelates. 
In our first 
attempt to 
demonstrate the 
versatility and 
the advantages 
of DO3AAHA 
as a bifunctional 
chelator, it was 
attached to an 
activated PEG 
(polyethylene glycol) with Mn = 750, which afforded DO3AAHAPEG750 (1,4,7,10-
tetraazacyclododecane-1-(6-amino(PEG750))hexanoic-4,7,10-triacetic acid – Figure 1b). 
Adding PEG units to chelating frameworks is known to improve the pharmacokinetic 
properties of the resulting chelates [3]. 
The relaxivity (r1 and r2) of the Gd(III) chelates of both ligands was measured at 20 
MHz at 25 and 37 °C. The dependence of 1/T1 on the temperature and pH was also studied. 
The kinetic stability of [Gd(DO3AAHA)]
-
 was confirmed performing a competition experiment 
with Zn
2+
. 
The biodistribution of the 
67
Ga-labeled chelates was investigated in Wistar rats. 
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